Portfolio company
SIRAKOSS
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
SIRAKOSS manufactures nanosynthetic bone graft substitutes for surgeons to facilitate bone repair and regeneration in trauma and spinal surgery patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Bonesupport
This company develops and manufactures injectable bioceramic bone graft substitutes for surgeons and healthcare providers to treat bone voids, defects and infections.
BBS-Bioactive Bone Substitutes
This company develops reindeer-derived bone graft substitutes for orthopaedic surgeons treating bone fractures and defects.
Kuros Biosciences
This company develops bone graft technologies and orthobiologics for surgeons and hospitals to facilitate bone healing and tissue regeneration.
OssDsign
OssDsign develops and provides synthetic bone grafts and orthobiologic products for surgeons to assist in spinal fusion and bone reconstruction procedures.
IBI
This company develops and manufactures biomimetic bone substitutes for orthopaedic and dental surgeons to support bone tissue regeneration.
CERHUM
This company manufactures 3D-printed bioceramic bone grafts and patient-specific implants for surgeons performing maxillofacial, dental, and orthopaedic reconstructions.
GreenBone
This company produces rattan wood-derived bone substitutes for adult patients undergoing orthopedic surgery to treat severe bone defects and fractures.
SI-BONE
This company develops and sells implants and surgical systems for the treatment of musculoskeletal disorders in the sacropelvic anatomy for surgeons and hospitals.
